The Lewis rat, an inbred rat strain susceptible to several well-characterized experimental autoimmune diseases, provides a good model to study peptide-mediated immunotherapy. 
Introduction
The inbred Lewis rat strain is extremely prone to experimental size of antigens to be presented (17, 18) . To establish a representative display of the entire protein assortment by autoimmune diseases (1-10). In these processes autoreactive CD4 ϩ T cells play a pivotal role (1-10). CD4 ϩ T cells recognize merely a few different MHC molecules, both class I and class II MHC molecules appear to be able to bind a wide variety a complex formed between a processed antigen fragment and a particular MHC class II molecule on the surface of of peptides (12) . Nonetheless, peptide binding is observed to be allele-specific. This allele specificity is largely dictated antigen-presenting cells (APC) with their TCR (11, 12) . MHC class II molecules are polymorphic αβ heterodimers that by polymorphic pockets in the antigen binding cleft, that can accommodate suitable amino acid side chains resulting in mainly bind peptides derived from exogenous or membraneassociated proteins with a heterogeneous length of [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] high-affinity binding (17, 18) . Thus, structural requirements can be discerned for peptides that bind to specific MHC residues (13) (14) (15) (16) . The antigen binding site of class II is similar to the cleft described for MHC class I, but appears to be subtypes. Since peptides binding to class II MHC are heterogeneous in length, sequence alignment of eluted peptides is open at the ends, imposing essentially no constraints on the rather complicated (14, 15, (19) (20) (21) (22) (23) . Alternative approaches to ant T cell epitope in guinea pig MBP-induced EAE (1). The amino acids of MBP72-85 are numbered with respect to the identify peptide-MHC binding motifs are based on truncation and substitution analysis of known MHC class II binding bovine MBP that contains a histidine-glycine insertion at positions 76 and 77. Peptide IRBP1181-1191 was synthesized peptides (24) (25) (26) (27) (28) (29) (30) (31) (32) and phage-expressed large random peptide libraries (33, 34) . Using these approaches, binding motifs, using t-Boc chemistry on an Applied Biosystems (Forster City, CA) model 430A peptide synthesizer. Large quantities of describing peptide 'anchor' residues in fixed positions relative to one another, have been reported for a number of human peptides hsp65 180-188, hsp65 180-188L 183 →A, MBP72-85, MBP72-85 D 81 →A and OVA323-339 were synthesized and murine class II MHC molecules (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) .
Disease-related MHC class II binding peptides have been by standard solid phase Fmoc chemistry (48) . All peptides were analyzed and purified by reverse-phase HPLC, and described to prevent induction of autoimmunity very efficiently in several experimental autoimmune models (35) (36) (37) . Such (if necessary) checked by fast atom bombardment mass spectrometry. Peptide concentrations were determined using competitor peptides structurally related to a defined T cell epitope have been shown to actively modulate the T cell a BCA protein assay (Pierce, Rockford, IL). response to the original T cell epitope, through mechanisms MHC-peptide binding assay other than MHC blockade (37-41). In order to design potent modulatory peptides, it is important to understand the molecuThe MHC-peptide binding studies were performed using a lar characteristics of the interaction between peptide-MHC previously described binding assay on isolated MHC molecand TCR.
ules (44). Briefly, rat RT1.B L molecules were affinity purified In the Lewis rat most CD4 ϩ T cell responses associated and detergent-solubilized from cell lysates of the concanavalin with autoimmune diseases are MHC class II RT1.B L restricted A-activated MHC class II-positive Z1a T cell line using the (1-9). This MHC product is the equivalent of murine I-A and mAb OX6 coupled to CNBr-activated Sepharose-4B beads. human HLA-DQ (42, 43 To characterize the structural requirements for peptide binding to Lewis rat class II RT1.B L molecules, substitution analogs employed. Peptides were obtained as C-terminal amides from 7.5 mg resin/peptide (0.21 meq/g, PAL resin; Milligen, Ettenof the RT1.B L binding peptide hsp65 180-188 were examined in a competition assay on isolated RT1.B L molecules. Previous Lewr, The Netherlands). The synthetic peptides used in the present study corresponding to defined T cell epitopes studies indicated that for proliferation of the A2b T cell clone, which is specific for hsp65 180-188, the 180-186 sequence together with known MHC restriction elements are shown in Table 1 . Peptide sequences are presented in single amino was the minimal core region (49) . Considering this data, a series of hsp65 180-188 analogs carrying substitutions at acid lettering codes. Peptide analogs used in this study were derived from: the hsp65 180-188 (TFGLQLELT) sequence of positions 180 through 186 were analyzed for MHC binding ( Table 2 ). The original hsp65 180-188 peptide was an inter-65 kDa Mycobacterium tuberculosis heat shock protein (10) and from MBP72-85 (QKSQRSQDENPV), the immunodominmediate binder (ID 50 ϭ 32-64 µM). Substitution of threonine at position 180 into an alanine or a relatively small hydrophobic Table 3 . Competitive binding of MBP72-85 single alanine analogs to purified RT1.B L residue (L) did not drastically change the binding affinity, while substitutions into bulky hydrophilic residues (E or K) strongly decreased the binding affinity. At position 181 substitution of phenylalanine into a negatively or positively charged residue (E or K) resulted in poor or non-RT1.B L binding peptides, while substitution into an alanine or an uncharged hydrophilic (T) residue only marginally affected RT1.B L binding. Replacement of the small glycine at position 182 by a bulky hydrophobic (F) or bulky negatively charged hydrophilic (E) residue essentially did not change the binding characteristics, while introduction of a positive charge (K) strongly reduced the binding affinity. At position 183, the most striking effect was the enhanced MHC binding of the alanine substituted analog peptide. Substitution of the glutamine at position 184 into small (A or S) residues strongly decreased the binding affinity. At position 185 substitution of leucine into another hydrophobic residue (V) or into small residues (A or S) did not influence RT1.B L binding, while bulky hydrophilic charged residues (D or K) had a negative effect on binding. At position 186 it appeared that a negatively charged hydrophilic amino acid was absolutely required for RT1.B L binding.
Analysis of RT1.B L binding capacities of MBP72-85 single substitution analogs
To verify the results obtained with the hsp65 180-188 analogs, the binding properties of single alanine substitution variants of MBP72-85 were examined. As shown in Table 3 (Table 2) , MBP72-85 and hsp65 180-188 were aligned as shown in Table 4. residue (E or K) strongly reduced the RT1.B L binding affinity, For both peptides it was seen that alanine substitutions of while an alanine or a uncharged hydrophilic (T) substitution the aligned glutamic acid (hsp65 180-188 E 186 ; MBP72-85 did not affect the binding affinity (Table 2) . Therefore, we E 82 ) or glutamine (hsp65 180-188 Q 184 ; MBP72-85 Q 80 ) concluded that at this position in a peptide, size constraints residues decreased the RT1.B L binding affinity drastically, do not play an important role, but that the presence of either while substituting the residue preceding this glutamine into a negatively or positively charged residue has a negative alanine increased the binding affinity. Furthermore, the effect on RT1.B L binding. Interestingly, although the native increased binding affinity of the MBP72-85 alanine analog in peptide MBP72-85 is lacking the hydrophobic or small (A or which the aspartic acid at position 81 was substituted also G) residue at position 81, which is present in hsp65 180-188 fitted the results obtained with the hsp65 180-188 analogs in at position 185, and which seemed to be important for RT1.B L which substitution of the leucine at position 185 into charged binding, the MBP72-85 peptide had a higher RT1.B L binding hydrophilic residues reduced the RT1.B L binding affinity, while affinity (ID 50 ϭ 16-32 µM) than hsp65 180-188 (ID 50 ϭ 32-substitution into an alanine did not affect the binding affinity. 64 µM). A possible explanation for this discrepancy could be Substituting the MBP72-85 S 74 into an alanine strongly that, since hsp65 180-188 is a rather short peptide for MHC decreased the RT1.B L binding affinity, in contrast to the class II binding, it is lacking a residue which is important for marginally decreased binding affinity of the hsp65 180-188 RT1.B L binding and which is present in MBP72-85. To test this alanine analog of position T 180 . On the contrary, the alanine hypothesis, peptides hsp65 176-190 (EESNTFGLQLELTEG) substitution of the positively charged arginine at position 78 and hsp65 178-188 (SNTFGLQLELT) were tested for RT1.B L in MBP72-85 slightly increased the binding affinity, while binding. It appeared that these longer peptides indeed were in the hsp65 180-188 peptide a positive charge at the better RT1.B L binders (ID 50 Ͻ 32 µM) than hsp65 180-188 corresponding position had a more pronounced negative (ID 50 ϭ 32-64 µM) (data not shown). Since no differences in effect on RT1.B L binding.
binding affinity between hsp65 178-188 and 176-190 were At position 75 of the MBP72-85 peptide, the RT1.B L binding found, the most likely explanation is that hsp65 180-188 is affinity was not affected by substituting the glutamine into an lacking a N-terminal MHC anchor residue, which is present alanine. For hsp65 180-188 it was shown that substituting the phenylalanine at position 181 into a charged hydrophilic in peptide hsp65 178-188. (Table 2) . A clustering of three residues, large hydroresidues of T cell epitopes more in general, several nonphilic/small or hydrophobic/negatively charged was only autoimmune related T cell epitopes restricted to murine and found in the good binders (ID 50 Ͻ 16 µM) and in one of the human counterparts of RT1.B L (I-A and HLA-DQ), as well as two intermediate binders (ID 50 ϭ 16-64 µM). Small residues I-E and HLA-DR binding epitopes (Table 1) , were tested in at the first position within this cluster, which negatively affect the RT1.B L -peptide binding assays (Table 5) . Furthermore, RT1.B L binding, were only present in the relatively poor RT1.B L all peptides tested were aligned according to the residues binder (ID 50 ϭ 64-256 µM) and in two out of four non-RT1.B L important for RT1.B L binding as defined by the hsp65 180-binders (ID 50 Ͼ 256 µM). Only in OVA323-339 was the entire 188 and MBP72-85 analog peptides, and indicated in bold cluster of three residues preceded by an alanine, which further in the upper-part of Table 5 . After best-fit alignment it appeared increases the binding affinity. At position 3, the corresponding that in two out of four non-RT1.B L binders (ID 50 Ͼ 256 µM) a position 180 of hsp65 180-188, only LolP1 and IBV67-83 had negatively charged residue at relative position 9 could be a negatively contributing bulky residue. Furthermore, both aligned, while this was present in all RT1.B L binding peptides.
good, one of the intermediate and, depending on the alignFor all RT1.B L binders (ID 50 Ͻ 256 µM), a small or hydrophobic residue was present upstream the negatively charged residue, ment, one or two non-RT1.B L binders had a small or uncharged (Table 6 ). Although all peptides contained a positions 4 and 5 do not play an important role in RT1.B L negatively charged residue at relative position 9, only two out binding, the presence of any charged residue at position 4 of eight contained the entire P7, P8 and P9 cassette as was or a positive charge at position 5 had a negative effect on present in good binders (Table 5) . At the N-terminus, four out RT1.B L binding (Tables 2 and 3 ). It appeared that such of eight epitopes contained the P1 and five out of eight inhibitory residues were present in several peptides throughthe P3 preference residues (Table 6) , while strong binders out all different categories of RT1.B L binding affinity.
contained both P1 and P3 ( have to be defined. However, for both search profiles the integrating all these data (Fig. 1) . It appeared that for RT1.B L negative charge at P9 was used as a prerequisite for RT1.B L binding a cluster of residues at relative positions 7, 8 and 9
binding. If the protein search for RT1.B L binding T cell epitopes plays a major role. Relative position 9 seemed to be the most important MHC anchor position. Only a negatively charged was done with a very stringent search profile; P1 ϩ P3 ϩ P7 ϩ P8 ϩ P9, exclusively good binders (Table 5 ) would be (E or D) residue is allowed at this position. Relative position 8 also plays an important role in RT1.B L binding. Only hydroselected. Broadening the search profile to (P1 or P3) ϩ (P7 or P8) ϩ P9 will select, in addition to the good binders, also phobic or small residues have a positive contribution, while charged residues have a negative influence on RT1.B L bindall intermediate binders (Table 5 ) and seven out of eight RT1.B L -restricted autoimmune epitopes (Table 6) , while none ing. At relative position 7 large hydrophilic residues may increase RT1.B L binding affinity, while small residues have a of the RT1.B L non-binders (Table 5) , fitted this criterion. The only autoimmune-associated T cell epitope which would not negative contribution. At the N-terminus of a peptide mainly relative positions 1 and 3 are important for RT1.B L binding.
be selected, IRBP1181-1191, was shown to be a very poor RT1.B L binder (ID 50 128-256µM). However, this peptide binds At position 1, only small or uncharged hydrophilic residues were found in good RT1.B L binders, while at position 3 besides well to the other MHC class II molecule of the Lewis rat, RT1.D L (M. Wauben, pers. commun.). To test how much non-bulky uncharged hydrophilic (S or T), hydrophobic residues are also allowed. More bulky hydrophilic residues have nonamers would be selected within a certain protein by using these search profiles 10 non-related proteins were screened. a detrimental effect on RT1.B L binding. Although position 4 is probably no MHC anchor, either negatively or positively
The most stringent profile selected 0.9 Ϯ 0.4% of all possible overlapping nonamers within these proteins, while using the charged residues at that position decrease the RT1.B L binding affinity. In addition, positions 5 and 6 play a less important profile for the identification of intermediate binders, 6.6 Ϯ 2.0% of all possible nonamers were selected (data not shown). role in high-affinity RT1.B L binding. However, the presence of a positive charge at position 5 has a negative influence on This indicates that screening proteins with these search profiles will result in manageable numbers of nonamers RT1.B L binding, while at position 6 an alanine can increase the RT1.B L binding affinity. fulfilling the criteria. Table 6 . Alignment of well-defined RT1.B L -restricted autoimmune-associated T cell epitopes a Indicates the species of which the sequence is derived. Residues indicated in bold or underlined italics respectively contribute positively or negatively in RT1.B L binding.
Discussion
peptide-MHC binding involving hydrogen bonds between the main chain atoms along the peptide and mostly conserved In this paper the definition of an extended peptide-MHC MHC residues, five side chains of the peptide were accombinding motif for rat MHC class II RT1.B L molecules has been modated by polymorphic pockets in the HLA-DR1 binding described, which is based on peptide substitution analogs of site, determining the specificity of the different MHC class II the rat T cell epitopes hsp65 180-188 and MBP72-85 tested proteins (18) . The nature and spacing of pockets in MHC in peptide-MHC binding assays on isolated MHC molecules.
class II molecules differs slightly for different MHC class II Although numerous allele-specific motifs have been identified molecules (50) . The P1 pocket, the largest and most hydrofor human and murine class II MHC molecules (14, 15, (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) , phobic pocket in the DR1-peptide binding site, appears to so far no molecular characteristics of MHC class II-peptide be the major determinant for HLA-DR1 binding (18, 27 ). Among interactions were described for the rat. different HLA-DR proteins, much of this pocket is conserved The peptide-RT1.B L binding motif contains two clusters of (all MHC α chain residues, and Fβ89 and Tβ90), leading to residues important for MHC binding. At the N-terminus of a a rather general preference for a large hydrophobic amino peptide relative positions 1 and 3 are involved in RT1.B L acid side chain at this position (34) . More importantly, in all binding while, more C-terminal positions 7, 8 and 9 are well-defined class II ligand motifs known so far, including important for RT1.B L binding. Most RT1.B L binding peptides human DR, DQ, DP as well as murine I-E molecules, a do not contain all anchors. However, a negatively charged preference for a hydrophobic anchor residue at P1 is present residue at position 9 is a prerequisite for RT1.B L binding, (reviewed in 51). If the pocket specificity of RT1.B L is presuggesting an obligatory role for the P9 anchor. All other dicted, assuming homology with HLA-DR1, the P1 pocket is anchors (P1, 3, 7 and 8) appeared to be auxiliary, in that probably much smaller, more shallow and hydrophilic in either of them can be omitted without complete loss of peptide RT1.B L as compared to other known MHC class II sequences. binding. Although relative position 4 is no MHC anchor
In particular, the presence of a positively charged arginine at position, charged hydrophilic substitutions strongly position β89 can influence the pocket specificity. As defined decreased the binding affinity. At relative position 5 no in this paper, at position 1 of the RT1.B L -peptide binding preference residues were found; however, positively charged motif a small or uncharged hydrophilic residue is preferred. residues had a negative effect on RT1.B L binding. Since, Herewith, the RT1.B L -peptide binding motif is the first MHC negatively charged residues did not exhibit any detrimental class II-peptide binding motif lacking the hydrophobic P1 effect on RT1.B L binding affinity, the inhibitory effect of a anchor. Furthermore, in DR1 the P9 pocket is a small hydropositive charge at position 5 is most likely due to repulsive phobic pocket, which can accommodate a peptide side chain electrostatic interactions. At position 6 an alanine has a of an auxiliary anchor residue, while for RT1.B L this pocket positive effect on RT1.B L binding. Since it is unlikely that this accommodates the only obligatory anchor side chain. Position residue contributes significantly to the binding energy of the 57 of the MHC β chain plays an important role in defining the peptide, steric constraints in this part of the binding site specificity of pocket 9 (17, 18) . If an aspartic acid is present probably play the most important role.
at position β57, this residue can form a salt bridge with the The understanding of peptide-MHC class II binding is conserved arginine at position α76 (17, 18) . In that case the tremendously increased after the crystallization of HLA-DR1 with the HA306-318 peptide (18) . Besides the rather universal P9 pocket is rather degenerate and tolerates positive charges tively low-affinity binders. Previously, based on alignment of several autoimmune-associated T cell epitopes of the Lewis rat, it has been suggested that a putative RT1.B L -peptide References binding motif (S-x-x-x-x-x-E) could be used to identify self- RT1.B L binding autoimmune-associated T cell epitopes (Table   2 Offner, H., Hashim, G. A., Celnik, B., Glang, A., Li, X., Burns, 6) do not fulfill this criterion. In contrast, using the search the Lewis rat.
Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J. Exp. Med. 180:817.
